Phenylketonuria differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Line 6: | Line 6: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Conditions coursing with: | Conditions coursing with: | ||
* <u>Intellectual developmental disability:</u> cerebral palsy, inborn errors of metabolism (IEM) such as fatty acid oxidation disorders, lysosomal disorders, hyperhomocysteinemias and amnio acid disorders, creatine deficiencies. <ref name="pmid25433678">{{cite journal| author=Leach EL, Shevell M, Bowden K, Stockler-Ipsiroglu S, van Karnebeek CD| title=Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue= | pages= 197 | pmid=25433678 | doi=10.1186/s13023-014-0197-2 | pmc=PMC4273454 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25433678 }} </ref> | |||
Intellectual developmental disability | * <u>Seizures:</u> Inherited neurotransmitter and non-neurotransmitter disorders, primary seizures.<ref name="pmid25758715">{{cite journal| author=Mercimek-Mahmutoglu S, Sidky S, Hyland K, Patel J, Donner EJ, Logan W et al.| title=Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study. | journal=Orphanet J Rare Dis | year= 2015 | volume= 10 | issue= 1 | pages= 12 | pmid=25758715 | doi=10.1186/s13023-015-0234-9 | pmc=PMC4342151 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25758715 }} </ref> | ||
* <u>Anxiety and/or depression</u>: IEM such as urea cycle disorders, organic acidurias, maple syrup urine disease, tyrosinemia type 1.<ref name="pmid25344299">{{cite journal| author=Zeltner NA, Huemer M, Baumgartner MR, Landolt MA| title=Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic review. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue= | pages= 159 | pmid=25344299 | doi=10.1186/s13023-014-0159-8 | pmc=PMC4219016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25344299 }} </ref> | |||
Seizures: Inherited neurotransmitter and non-neurotransmitter disorders, primary seizures.<ref name="pmid25758715">{{cite journal| author=Mercimek-Mahmutoglu S, Sidky S, Hyland K, Patel J, Donner EJ, Logan W et al.| title=Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study. | journal=Orphanet J Rare Dis | year= 2015 | volume= 10 | issue= 1 | pages= 12 | pmid=25758715 | doi=10.1186/s13023-015-0234-9 | pmc=PMC4342151 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25758715 }} </ref> | * <u>Characteristic urine odor</u>: maple syrup urine disease, methylmalonic and propionic acidemia.<ref name="pmid25205257">{{cite journal| author=Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA et al.| title=Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue= | pages= 130 | pmid=25205257 | doi=10.1186/s13023-014-0130-8 | pmc=PMC4180313 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25205257 }} </ref> | ||
Anxiety and/or depression: IEM such as urea cycle disorders, organic acidurias, maple syrup urine disease, tyrosinemia type 1.<ref name="pmid25344299">{{cite journal| author=Zeltner NA, Huemer M, Baumgartner MR, Landolt MA| title=Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic review. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue= | pages= 159 | pmid=25344299 | doi=10.1186/s13023-014-0159-8 | pmc=PMC4219016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25344299 }} </ref> | |||
Characteristic urine odor: maple syrup urine disease, methylmalonic and propionic acidemia.<ref name="pmid25205257">{{cite journal| author=Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA et al.| title=Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue= | pages= 130 | pmid=25205257 | doi=10.1186/s13023-014-0130-8 | pmc=PMC4180313 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25205257 }} </ref> | |||
==References== | ==References== |
Revision as of 21:54, 8 June 2015
Phenylketonuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Phenylketonuria On the Web |
American Roentgen Ray Society Images of Phenylketonuria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Differential Diagnosis
Conditions coursing with:
- Intellectual developmental disability: cerebral palsy, inborn errors of metabolism (IEM) such as fatty acid oxidation disorders, lysosomal disorders, hyperhomocysteinemias and amnio acid disorders, creatine deficiencies. [1]
- Seizures: Inherited neurotransmitter and non-neurotransmitter disorders, primary seizures.[2]
- Anxiety and/or depression: IEM such as urea cycle disorders, organic acidurias, maple syrup urine disease, tyrosinemia type 1.[3]
- Characteristic urine odor: maple syrup urine disease, methylmalonic and propionic acidemia.[4]
References
- ↑ Leach EL, Shevell M, Bowden K, Stockler-Ipsiroglu S, van Karnebeek CD (2014). "Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review". Orphanet J Rare Dis. 9: 197. doi:10.1186/s13023-014-0197-2. PMC 4273454. PMID 25433678.
- ↑ Mercimek-Mahmutoglu S, Sidky S, Hyland K, Patel J, Donner EJ, Logan W; et al. (2015). "Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study". Orphanet J Rare Dis. 10 (1): 12. doi:10.1186/s13023-015-0234-9. PMC 4342151. PMID 25758715.
- ↑ Zeltner NA, Huemer M, Baumgartner MR, Landolt MA (2014). "Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic review". Orphanet J Rare Dis. 9: 159. doi:10.1186/s13023-014-0159-8. PMC 4219016. PMID 25344299.
- ↑ Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA; et al. (2014). "Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia". Orphanet J Rare Dis. 9: 130. doi:10.1186/s13023-014-0130-8. PMC 4180313. PMID 25205257.